Unigel™ Fixed Dose Combination Softgels

At Sofgen Pharma, we go beyond traditional softgels, offering solutions ranging from single-unit dosage forms to multiple delivery systems within a single dose.

Softgels are an effective oral delivery system, especially for active ingredients with low solubility and/or permeability (BCS Classes ...

Discover our Chewable Softgel Platform – Chewgels™, a chewable soft capsule solution designed as a line extension for existing products or as an innovative format for new developments. With unique ingredients, customized shapes, and appealing flavors, this platform enables versatile formulations across mul...

At Funtrition™, we focus on delivering a complete experience in every bite of our delicious gummies — the art you can taste and the science you can trust. From gelatin to plant-based technologies and sugar-free formulations, we believe good nutrition should be enjoyable, not boring.

At Funtritio...

Versagel™ is our advanced vegetarian softgel platform designed to meet the growing demand for plant-based dosage forms without compromising performance or versatility. This technology enables the encapsulation of complex formulations, including high-viscosity liquids and semisolids, offering brands a flexi...

We offer fully assistance for development, formula optimization, and encapsulation of CBD-THC products. Soft gelatin capsules are the ideal dosage form considering both bioavailability and stability of Cannabis medicinal products. Additionally, our unique and patenteted Unigel technology offers a unique pl...

Innovative technologies designed to improve therapeutic adherence. Meet Gtabs™, our gelatin-coated tablet technology. This platform features single or two-tone gelatin coatings that effectively mask unpleasant tastes and odors, enhance product appearance, and help protect against counterfeiting.

...

During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.  

Discover how our passion for innovation turns into revolutionary technologies that are ideal for consumers health and nutrition. Unigel™ is the only technology available for fixed dose combinations, that allows multiple ingredients to co-exist in one single dose

Procaps, developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents, has partnered with CPHI Barcelona to support sustainability initiatives, to be highlighted at the CPHI Worldwide event in Barcelona in October 2023. 

Sofgen Pharma is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Sofgen Pharma has a direct presence in 13 countries in Latin America and, as of December 31, 2020, had more than 4,700 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions. 

In our packed out content sessions at CPHI Barcelona this year we focus on some of the hottest topics coming up in the pharma industry, with each track sponsored by a leading expert in the field.   

More than 4 decades developing medical solutions for the world.

Explore the series of Learning Labs at CPHI North America across several product innovation categories in which thought leaders at our exhibitors showcase their extensive expertise in all areas of the pharma supply chain, offering industry insights across drug manufacturing, outsourcing, pharma ingredients, drug delivery and packaging.

This webinar originally aired as part of CPHI Discover - 17-28 May 2021 Latin America is a diverse market with a huge population that has commanded the attention of pharma companies as one to watch. This session will explore how the potential of this dynamic market can be tapped into. Overview of the current market opportunities & challenges across key markets - Brazil, Mexico, Chile, Colombia, Argentina and Central America. Key therapy areas & most promising markets Innovation landscape Potential drivers to the increasing internationalization of the LatAm Pharma Market What has been the impact of the pandemic on the Latam pharmaceutical market?

As consumers become increasingly knowledgeable about the different delivery formats available, so they continue to demand more from both pharmaceutical and nutraceutical products. As a result, the race to create the next ‘super pill’ has intensified. One of the leading contenders in this race is Unigel softgel.

This webinar originally aired as part of CPHI Discover - 17-28 May 2021 While plant-based diets continue to grow in popularity, the desire to live and act more sustainably and healthfully is on the rise. With our Vegetarian Softgel Technology, Versagel™, companies can now offer their patients and consumers Non-GMO, plant-based softgel products as an optimal solution for their latest demands without losing the versatility and benefits of regular softgel capsules. Changing to a plant-based alternative should not affect overall product performance and quality. Versagel™ offers not only great appearance, but an overall competitive edge, the cornerstone for your next big project. Join us!

The Pharma industry is shifting from volume to value – addressing smaller patient populations and rare diseases. 3D printing (3DP) technologies have a transformational role to play. However, 3DP comprises an array of different additive manufacturing technologies of which only some can be adapted to the use in pharmaceutics. This session will discuss the use of 3D printing in a hospital setting to prepare personalised therapies for paediatric patients. For the first time, 3D printing offers a feasible, rapid and automated approach to prepare oral tailored-dose therapies for patient improving safety and adherence to the treatment. Podcast aired as part of the CPHI Festival of Pharma

A breakthrough in oral drug delivery technology is helping the pharmaceutical industry to cut plastic waste

The global demand for ​gummy supplements has witnessed an unprecedented surge in recent years, driven by factors such as convenience, indulgence, and efficacy.

Innovations in gummy delivery technology allow brands to cater to consumer demand for efficacious, great-tasting supplement products.

Funtrition’s new gummy facility in Florida amplifies reach, doubling capacity and reinforcing commitment to global nutraceutical excellence.

We are an integrated CDMO that offers end-to-end solutions, from developmentthroughout delivery, in innovative Softgel technologies for pharma andhealthcare companies interested in launching novel products within NorthAmerica and other Highly regulated markets.

Join Frances Zipp, where she will delve into the latest innovations and developments in drug manufacturing and how the industry can embrace 4.0

The pharmaceutical industry faces significant challenges in bringing new drugs to market due to the complexities of the R&D process. These challenges include high costs, lengthy development timelines, and a low success rate. In response to these challenges, a new approach to R&D has emerged: R&D 4.0.
R&D 4.0 leverages advanced technologies such as Deep Learning, Machine Learning, Artificial Intelligence, 3D Printing; among others, to streamline the drug development process and reduce time-to-market. In this webinar, join Procaps Group to explore the role of these technologies to improve the pharmaceutical development process. We will showcase real-world case studies performed, including the utilization of three-dimensional printing technology in the development of complex and customized drug delivery systems. Additionally, we will discuss how Deep Learning algorithms can estimate moisture levels in gelatin mass at different stages of the manufacturing process using spectral data. This approach provides real-time data to optimize the production process and ensure consistent quality. Furthermore, we will explain how Machine Learning algorithms, specifically the Pearson correlation coefficient, are being used to analyse the interaction of different excipients in drug formulations. This analysis helps in optimizing drug formulations to improve stability and efficacy. Explore with Procaps Group the exciting potential of R&D 4.0 as a leading Softgel CDMO/CMO.
Discussion topics To gain an understanding of R&D 4.0 in the pharmaceutical industry, including its key principles and how it can help reduce time-to-market To learn about the benefits and challenges of utilizing advanced technologies such as 3D printing, Deep Learning, and Machine Learning in pharmaceutical development To explore real-world examples from Procaps on how these technologies have been used in pharmaceutical R&D, including in the development of complex drug delivery systems and the optimization of drug formulations specifically in Softgel advanced technologies Get a deeper insight on who Procaps Group is and how as a leading Softgel CDMO/CMO is incorporating these trends and technologies to achieve better time-to-market for its partners around the world

Digital transformation is a key area of development in pharma, but potential can be limited by regulatory roadblocks, a talent gap and integration complexities. Join our experts to gain insights into overcoming challenges and implementing the latest technologies: Becoming tech-led, not led by technology Managing change effectively Talent acquisition and onboarding Scaling across the organisation to avoid silos

Join our panel of experts to explore the tangible opportunities AI brings to pharma manufacturing: Improving batch manufacturing processes Efficient quality assurance and regulatory compliance Defining the role of chatbots and the potential for improving training and compliance standards in manufacturing set-ups Reviewing how AI can improve patient engagement